Biotechnology Equipment: Biotechnology Business

biotechnology business

The short interest data are out for the February 27 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them. A single failed clinical trial can mean disaster for a stock. NEW YORK – Shares of some top biotechnology companies were down at the close of trading: Amgen Inc. fell $1.43 or .9 percent, to $153.58. Biogen Idec fell $1.31 or .3 percent, to $414.20. Celgene Corp. fell $.08 or .1 percent, to $118.33. Gilead Sciences Yet biotech drugs are composed from living organisms “The production of biosimilars, therefore, is not part of our business model,” the company said. AbbVie also said in an e-mail that it’s focusing on innovative therapies. The investigation by a law firm focuses on whether certain statements regarding Puma Biotechnology’s business, its prospects and its operations were materially false and misleading at the time they were made. On July 22, 2014, Puma Biotechnology Inc LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced the initiation of a Phase II trial of Puma's investigational drug PB272 (neratinib) for the extended adjuvant treatment of breast The Los Angeles Biotech Summit draws leaders from business, academia and government to discuss ways to build the industry and, in turn, create more jobs. Panel topics at the summit include job creation through university-spawned companies and economic and .

Now that AbbVie ($ABBV) has managed to astonish just about everyone in the biopharma business with its $21 billion takeover seeing as how the Big Biotech is now the clear leader in immuno-oncology, where it could be in line for $15 billion in peak Shares of Watertown biotech Tetraphase Pharmaceuticals Inc. fell Wednesday after the company disclosed plans to sell 3.5 million shares in a public stock offering. The clinical-stage company, a developer of antibiotics, would raise about $118 million with FDA approves first lower-cost biotech drug MATTHEW PERRONE, AP Business Writers LINDA A. JOHNSON, AP Business Writers northwestgeorgianews.com WASHINGTON (AP) — Federal health officials on Friday approved the first lower-cost copy of a biotech drug in But today, the biotech boom isn't an isolated phenomenon. Equities have lifted off everywhere. But while valuations across many indexes and business sectors are very high, none of it approaches the nutty, stratospheric levels of dot-com stocks in 2000. .

biotechnology business MD Anderson Children's Art Project Allows Child Cancer Patients to 170 x 95 · 4 kB · jpeg
biotechnology business Sea Otter 172 x 140 · 11 kB · jpeg
biotechnology business Article about top science/biotechnology employers, but some great info 160 x 160 · 4 kB · jpeg
biotechnology business e4236eedf641927095dacde6f8710ff1. 122 x 90 · 5 kB · jpeg
biotechnology business GRIFOLS :: Working at Grifols 143 x 97 · 8 kB · jpeg
biotechnology business Cynthia Smith Appointed Chief Commercial Officer of ZS Pharma 192 x 125 · 4 kB · jpeg
biotechnology business Genetically Modified Food 110 x 150 · 5 kB · jpeg
biotechnology business TITLE_IMG8 IMG_RES8
biotechnology business TITLE_IMG9 IMG_RES9
biotechnology business TITLE_IMG10 IMG_RES10